Rick Thompson is the CEO of Findacure (Cambridge, UK).
In his current position, Thompson oversees Findacure’s strategy and development, major funding applications and maintains Findacure’s scientific projects.
Previously, Thompson served as Findacure’s first Scientific Officer, and then Head of Research, helping to develop the charity’s proof-of-concept study for the innovative drug repurposing social impact bond.
Thompson aims to encourage industry engagement with rare disease patient groups, promoting an open and collaborative approach to rare disease research and patient support.
Thompson hold a Doctor of Philosophy degree in Evolutionary Biology.